SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $507,095 | -71.4% | 4,428 | -65.6% | 0.08% | -69.3% |
| Q1 2023 | $1,771,942 | -25.9% | 12,856 | -30.4% | 0.24% | -27.8% |
| Q4 2022 | $2,392,306 | +82.6% | 18,462 | +55.7% | 0.34% | +79.8% |
| Q3 2022 | $1,310,000 | +421.9% | 11,854 | +269.4% | 0.19% | +337.2% |
| Q1 2022 | $251,000 | -81.9% | 3,209 | -82.8% | 0.04% | -76.6% |
| Q1 2021 | $1,388,000 | +232.9% | 18,621 | +526.5% | 0.18% | +247.2% |
| Q3 2020 | $417,000 | – | 2,972 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |